CClinicalTrials.gg
Status unknownNCT05432063Updated Jun 27, 2022

Urdu Version of Oxford Shoulder Score Scale: Reliability and Validity Study

An observational study in Shoulder Pain, sponsored by Riphah International University. Status unknown at 1 site in Pakistan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-06-27.

Sponsored by Riphah International University · Observational

The sponsor has not verified this record recently (last verified Jun 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
105
Ages
18 Years and older
Sex
All
01

Study summary

The primary goal of this study is to translate and culturally adapt the Oxford Shoulder Score Scale into Urdu, as well as to assess its reliability and validity in the Urdu-speaking Pakistani community. This research will also look at the relationship between Oxford Shoulder Score Scale and the Shoulder Pain And Disability Index and Short Form - 36 scores for shoulder pain.

Read the detailed description

The English version of the Oxford Shoulder Score Scale will be translated and culturally modified into Urdu. The Oxford Shoulder Score Scale, as well as other correlation measures, will be disseminated among 104 individuals in the Pakistani Urdu speaking community, who will be chosen using a convenience sample approach and based on pre-defined inclusion and exclusion criteria. For the intra- and inter-observer validity and reliability of the Oxford Shoulder Score Scale, Shoulder Pain And Disability Index, and Short Form - 36, questionnaires will be filled on the same day by two observers, with a two-hour gap between the first and second application. This is the inter-observer evaluation. The third application for the intra-observer evaluation will be completed after 7 days. Statistical Package of Social Sciences Version 26 will be used to enter and analyses the data. The internal consistency will be assessed using the Cronbach alpha value. The test-retest reliability will be assessed using an inter-class correlation coefficient. The content validity, criteria and construct validity, as well as responsiveness, of the Oxford Shoulder Score Scale scale will be assessed.

02

Conditions studied

  • Shoulder Pain

Browse trials for

Keywords

  • Oxford Shoulder Score Scale
  • Urdu Version
  • Reliability
  • Validity
  • Shoulder Pain
03

In context

Shoulder Pain

707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.

This study's planned enrollment of 105 is above the median of 82 across 130 observational studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pakistani general population with shoulder pain.

Inclusion criteria

  • Age above 18 years
  • Documented cognitive impairment
  • Patient with shoulder instability
  • Acute traumatic shoulder injury

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years
  • Recent surgery
  • Pain origination from neoplasms
  • Systemic arthritic
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
105 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Oxford Shoulder Score Scale

    The OSS is a 12-item questionnaire that patients with a degenerative or inflammatory shoulder disease must complete. Each question includes five response options, each with a score range from 0 to 4. The overall score runs from 0 to 48 (worst to greatest).

    Time frame: 1st day

  2. Shoulder Pain And Disability Index

    The Shoulder Pain And Disability Index is a self-report questionnaire that evaluates pain and impairment in the shoulder. It is made up of 13 items divided into two subscales: pain (5 items) and disability (5 items) (8 items). Both subscales' items are rated on a scale of 0 to 10 (no pain or impairment) (the worst imaginable pain or so much difficulty on performing tasks that help is required).

    Time frame: 1st day

  3. Short Form - 36

    The SF-36 is a 36-question Health Related Quality of Life survey divided into eight sections: vitality, physical functioning, bodily pain, general health, physical role functioning, emotional role functioning, social role functioning, and mental health. Each component of the questionnaire can be given a score ranging from 0 to 100. The lower the score, the lower the quality of life for the subject.

    Time frame: 1st day

07

Study locations

1 of 1 sites recruiting
  • Ripah International University
    Faisalabad, Punjab 38000, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05432063
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Jun 27, 2022
Start date
May 30, 2021
Primary completion
Jul 1, 2022 (estimated)
Completion
Jul 1, 2022 (estimated)
Last update
Jun 27, 2022

Study contacts

Muhammad Kashif
Contact
kashif.shaffi@gmail.com
+92418777210
Muhammad Kashif
study chair · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion